How AR² Therapy Could Change the Future of Follicular Lymphoma

How AR² Therapy Could Change the Future of Follicular Lymphoma This episode of Med News Week, in partnership with OncoDaily, features Dr. Paolo Strati, Associate Professor at The University of Texas MD Anderson Cancer Center, discussing innovative frontline treatment strategies for indolent B-cell lymphomas and the future of chemotherapy-free care. In this Medical Spotlight interview, Dr. Strati shares his personal journey from an international medical graduate in Italy to becoming a leading lymphoma researcher and clinician. He discusses the importance of mentorship, patient advocacy, and scientific integrity, while also presenting the results of a Phase II clinical trial evaluating acalabrutinib, lenalidomide, and rituximab (AR²) as frontline therapy. The discussion highlights promising clinical outcomes, high complete response rates, the role of the tumor microenvironment, emerging biomarkers, and the future of chemotherapy-free treatment approaches. Dr. Strati also shares his long-term vision of achieving what many still consider impossible: curing follicular lymphoma. #FollicularLymphoma #BCellLymphoma #Immunotherapy SUBSCRIBE to get the latest #oncodaily    / @oncodailytv   Visit the OncoDaily Website : https://oncodaily.com Like OncoDaily on LinkedIn:   / oncodaily   Like OncoDaily on X (Twitter): https://x.com/oncodaily Follow OncoDaily on Instagram:   / oncodailynews   Follow OncoDaily on TikTok:   / oncodaily   Like OncoDaily on Facebook:   / oncodaily   SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter About OncoDaily OncoDaily is your trusted source for the latest oncology news, expert interviews, patient stories, and cutting-edge research. Our mission is to empower the global cancer community—patients, survivors, professionals, and advocates—with timely, credible information. Subscribe for weekly podcasts, expert conversations, and updates on groundbreaking cancer research. 🔔 New videos every day! 💻 Visit us at https://oncodaily.com/